June 26, 2024CorporateMicroVention Announces the Next Evolution in Stent Innovation: MicroVention’s LVIS™ EVO™ Intraluminal Support Device Now Available in the United StatesMicroVention Continues to Lead the Way in Innovation for both Ischemic and Hemorrhagic Stroke Treatment and Prevention
May 28, 2024CorporateTerumo Cardiovascular Announces 510(K) Clearance For The CDI OneView™ Monitoring SystemAll-new modular, expandable design displays up to 22 vital patient parameters with real-time convenience
Top Management Message Message from top management to shareholders and investors. /investors/management/message Corporate Governance /about/governance Compliance /about/compliance Leadership Team /about/leadership Business Risks Major risks that may affect the business performance and financial position of the Terumo Group are described. /investors/management/risk IR Policy /investors/management/ir_policy Disclaimer /investors/disclaimer